Cargando…
Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders
BACKGROUND: Individuals with substance use disorders (SUDs) are at increased risk for hepatitis C viral infection (HCV), and few studies have explored their treatment responses empirically. The objective of this study was to assess interferon alpha therapy (IFN) completion and response rates among p...
Autores principales: | Huckans, Marilyn S, Loftis, Jennifer M, Blackwell, Aaron D, Linke, Alex, Hauser, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781072/ https://www.ncbi.nlm.nih.gov/pubmed/17222348 http://dx.doi.org/10.1186/1747-597X-2-4 |
Ejemplares similares
-
Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction
por: Loftis, Jennifer M., et al.
Publicado: (2013) -
Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence
por: Loftis, Jennifer M., et al.
Publicado: (2019) -
Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study
por: Huckans, Marilyn, et al.
Publicado: (2015) -
Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection
por: Huckans, Marilyn, et al.
Publicado: (2014) -
Methamphetamine use alters human plasma extracellular vesicles and their microRNA cargo: An exploratory study
por: Sandau, Ursula S., et al.
Publicado: (2020)